-+ 0.00%
-+ 0.00%
-+ 0.00%

Ladenburg Thalmann Initiates Coverage On Nutex Health with Buy Rating, Announces Price Target of $336

Benzinga·10/26/2026 16:26:12
Listen to the news
Ladenburg Thalmann analyst Jeffrey Cohen initiates coverage on Nutex Health (NASDAQ:NUTX) with a Buy rating and announces Price Target of $336.